Riskpilot← Back to searchSign inGet full accessCurandum AB
ABActiveOrg 5567036362Kasenvägen 45General medical practice activities · NACE 8621Est. 20060 employees
Revenue 2025
SEK 1
-100% vs 2024
EBITDA margin
-2160000.0%
-130% vs 2024
Equity ratio
96.9%
Financial strength
Net profit 2025
SEK -21K
-135% vs 2024
| Revenue | SEK 1 | -100% |
| EBITDA | SEK -22K | -130% |
| Net profit | SEK -21K | -135% |
| Total assets | SEK 392K | -26% |
| Equity | SEK 380K | -24% |
| Employees | 0 | — |
Legal name
Curandum AB
Org number
5567036362
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
9 maj 2006
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva allmänläkarvård, försäkringsmedicinska utredningar, företagshälsovård, utbildningar och handledning inom vårdyrket samt därmed förenlig verksamhet. Bolaget skall dessutom bedriva handel och förvaltning av värdepapper och därmed förenlig verksamhet.
Address
Kasenvägen 45
Email
inger.ja@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 431 | 389 | 198 | 96 | 0 |
| Staff expenses | — | −9 | −3 | −3 | −0 |
| EBITDA | 362 | 328 | 162 | 72 | −22 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 362 | 328 | 162 | 72 | −22 |
| Net financials | — | −0 | 0 | 1 | 1 |
| Profit before tax | 363 | 327 | 162 | 74 | −21 |
| Tax | −78 | −67 | −33 | −15 | — |
| Net profit | 285 | 260 | 129 | 59 | −21 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 845 | 769 | 622 | 533 | 392 |
| Equity | 743 | 653 | 567 | 501 | 380 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 102 | 116 | 55 | 32 | 12 |
| Total debt | 102 | 116 | 55 | 32 | 12 |
EBITDA margin
-2160000.0%
This company
15.8%
Market median
-13670986% vs market
20212025
Equity ratio
96.9%
This company
38.2%
Market median
+154% vs market
20212025
Return on equity
-5.4%
This company
18.4%
Market median
-129% vs market
20212025
Net profit margin
-2052900.0%
This company
8.1%
Market median
-25344544% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Curandum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inger Elisabeth Jakobsson | Board of Directors | 0 companies |
| Erik Gustav Marklund | Deputy Board Member | 0 companies |